Latest / In Focus by The Hindu
In Focus-Parley | Are lower MRPs on cancer drugs translating into affordable care?
While the National Pharmaceutical Pricing Authority (NPPA) recent trade margin rationalisation has reduced the prices of several anti-cancer medicines, experts say India needs comprehensive cancer care, stronger price regulation, greater transparency and expanded public healthcare provision to protect patients from catastrophic expenditure.
Are lower MRPs on cancer drugs translating into affordable care? Here, we discuss.
Guests: Dr. Indu Bhushan, bureaucrat, economist and the first CEO of Ayushman Bharat; Mr. K.M. Gopakumar, legal advisor, senior researcher and public health expert.
Host…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.